ARS Pharmaceuticals
The Key Account Manager at ARS Pharmaceuticals drives strategic growth by engaging top-volume practices and academic systems to accelerate adoption of neffy® and align account strategy with field execution.
ARS Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative treatments for severe allergic reactions and anaphylaxis. The company is best known for neffy, an intranasal epinephrine product designed as a needle-free alternative for emergency allergy treatment, and operates in the biotechnology and specialty pharmaceuticals industry.
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
Nov 10, 2025
ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy
Sep 13, 2025
ARS Pharmaceuticals Reports $72.2 Million U.S. Revenue for neffy® in 2025, Announces Phase 2b CSU Data Expected Mid-2026
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ARS Pharmaceuticals.
43% above the average for this role
Epinephrine nasal spray maker ARS sues Aptar alleging device supply monopoly
Oct 1, 2025
Key Account Manager, Oncology
viganhealth
Federal Account Director Southeast United States
alnylam
Rare Blood Disorder - CABLIVI Institutional Account Director (IAD), Ohio/PA West
sanofi us
Federal Account Director Northeast United States
alnylam
Key Account Manager - Atlanta /Nashville
8a7883c6700909c4017010d9b3290690
Key Account Manager - GI -Texas
Azurity Pharmaceuticals